<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-09-05" modified="2024-10-02" version="206" xmlns="http://uniprot.org/uniprot">
  <accession>O43719</accession>
  <accession>D3DWG9</accession>
  <accession>Q59G06</accession>
  <accession>Q99730</accession>
  <name>HTSF1_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName evidence="22">17S U2 SnRNP complex component HTATSF1</fullName>
    </recommendedName>
    <alternativeName>
      <fullName evidence="21">HIV Tat-specific factor 1</fullName>
      <shortName evidence="21">Tat-SF1</shortName>
    </alternativeName>
  </protein>
  <gene>
    <name evidence="20 23" type="primary">HTATSF1</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="1996" name="Science" volume="274" first="605" last="610">
      <title>Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat.</title>
      <authorList>
        <person name="Zhou Q."/>
        <person name="Sharp P.A."/>
      </authorList>
      <dbReference type="PubMed" id="8849451"/>
      <dbReference type="DOI" id="10.1126/science.274.5287.605"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
    <scope>PROTEIN SEQUENCE OF 26-45; 62-79; 155-169; 199-210; 239-245 AND 410-428</scope>
    <scope>FUNCTION (MICROBIAL INFECTION)</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>TISSUE SPECIFICITY</scope>
    <source>
      <tissue>Promyelocytic leukemia</tissue>
    </source>
  </reference>
  <reference key="2">
    <citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
      <title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
      <authorList>
        <person name="Kalnine N."/>
        <person name="Chen X."/>
        <person name="Rolfs A."/>
        <person name="Halleck A."/>
        <person name="Hines L."/>
        <person name="Eisenstein S."/>
        <person name="Koundinya M."/>
        <person name="Raphael J."/>
        <person name="Moreira D."/>
        <person name="Kelley T."/>
        <person name="LaBaer J."/>
        <person name="Lin Y."/>
        <person name="Phelan M."/>
        <person name="Farmer A."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
  </reference>
  <reference key="3">
    <citation type="submission" date="2005-03" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <person name="Totoki Y."/>
        <person name="Toyoda A."/>
        <person name="Takeda T."/>
        <person name="Sakaki Y."/>
        <person name="Tanaka A."/>
        <person name="Yokoyama S."/>
        <person name="Ohara O."/>
        <person name="Nagase T."/>
        <person name="Kikuno R.F."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
    <scope>VARIANT ALA-478</scope>
    <source>
      <tissue>Brain</tissue>
    </source>
  </reference>
  <reference key="4">
    <citation type="journal article" date="2005" name="Nature" volume="434" first="325" last="337">
      <title>The DNA sequence of the human X chromosome.</title>
      <authorList>
        <person name="Ross M.T."/>
        <person name="Grafham D.V."/>
        <person name="Coffey A.J."/>
        <person name="Scherer S."/>
        <person name="McLay K."/>
        <person name="Muzny D."/>
        <person name="Platzer M."/>
        <person name="Howell G.R."/>
        <person name="Burrows C."/>
        <person name="Bird C.P."/>
        <person name="Frankish A."/>
        <person name="Lovell F.L."/>
        <person name="Howe K.L."/>
        <person name="Ashurst J.L."/>
        <person name="Fulton R.S."/>
        <person name="Sudbrak R."/>
        <person name="Wen G."/>
        <person name="Jones M.C."/>
        <person name="Hurles M.E."/>
        <person name="Andrews T.D."/>
        <person name="Scott C.E."/>
        <person name="Searle S."/>
        <person name="Ramser J."/>
        <person name="Whittaker A."/>
        <person name="Deadman R."/>
        <person name="Carter N.P."/>
        <person name="Hunt S.E."/>
        <person name="Chen R."/>
        <person name="Cree A."/>
        <person name="Gunaratne P."/>
        <person name="Havlak P."/>
        <person name="Hodgson A."/>
        <person name="Metzker M.L."/>
        <person name="Richards S."/>
        <person name="Scott G."/>
        <person name="Steffen D."/>
        <person name="Sodergren E."/>
        <person name="Wheeler D.A."/>
        <person name="Worley K.C."/>
        <person name="Ainscough R."/>
        <person name="Ambrose K.D."/>
        <person name="Ansari-Lari M.A."/>
        <person name="Aradhya S."/>
        <person name="Ashwell R.I."/>
        <person name="Babbage A.K."/>
        <person name="Bagguley C.L."/>
        <person name="Ballabio A."/>
        <person name="Banerjee R."/>
        <person name="Barker G.E."/>
        <person name="Barlow K.F."/>
        <person name="Barrett I.P."/>
        <person name="Bates K.N."/>
        <person name="Beare D.M."/>
        <person name="Beasley H."/>
        <person name="Beasley O."/>
        <person name="Beck A."/>
        <person name="Bethel G."/>
        <person name="Blechschmidt K."/>
        <person name="Brady N."/>
        <person name="Bray-Allen S."/>
        <person name="Bridgeman A.M."/>
        <person name="Brown A.J."/>
        <person name="Brown M.J."/>
        <person name="Bonnin D."/>
        <person name="Bruford E.A."/>
        <person name="Buhay C."/>
        <person name="Burch P."/>
        <person name="Burford D."/>
        <person name="Burgess J."/>
        <person name="Burrill W."/>
        <person name="Burton J."/>
        <person name="Bye J.M."/>
        <person name="Carder C."/>
        <person name="Carrel L."/>
        <person name="Chako J."/>
        <person name="Chapman J.C."/>
        <person name="Chavez D."/>
        <person name="Chen E."/>
        <person name="Chen G."/>
        <person name="Chen Y."/>
        <person name="Chen Z."/>
        <person name="Chinault C."/>
        <person name="Ciccodicola A."/>
        <person name="Clark S.Y."/>
        <person name="Clarke G."/>
        <person name="Clee C.M."/>
        <person name="Clegg S."/>
        <person name="Clerc-Blankenburg K."/>
        <person name="Clifford K."/>
        <person name="Cobley V."/>
        <person name="Cole C.G."/>
        <person name="Conquer J.S."/>
        <person name="Corby N."/>
        <person name="Connor R.E."/>
        <person name="David R."/>
        <person name="Davies J."/>
        <person name="Davis C."/>
        <person name="Davis J."/>
        <person name="Delgado O."/>
        <person name="Deshazo D."/>
        <person name="Dhami P."/>
        <person name="Ding Y."/>
        <person name="Dinh H."/>
        <person name="Dodsworth S."/>
        <person name="Draper H."/>
        <person name="Dugan-Rocha S."/>
        <person name="Dunham A."/>
        <person name="Dunn M."/>
        <person name="Durbin K.J."/>
        <person name="Dutta I."/>
        <person name="Eades T."/>
        <person name="Ellwood M."/>
        <person name="Emery-Cohen A."/>
        <person name="Errington H."/>
        <person name="Evans K.L."/>
        <person name="Faulkner L."/>
        <person name="Francis F."/>
        <person name="Frankland J."/>
        <person name="Fraser A.E."/>
        <person name="Galgoczy P."/>
        <person name="Gilbert J."/>
        <person name="Gill R."/>
        <person name="Gloeckner G."/>
        <person name="Gregory S.G."/>
        <person name="Gribble S."/>
        <person name="Griffiths C."/>
        <person name="Grocock R."/>
        <person name="Gu Y."/>
        <person name="Gwilliam R."/>
        <person name="Hamilton C."/>
        <person name="Hart E.A."/>
        <person name="Hawes A."/>
        <person name="Heath P.D."/>
        <person name="Heitmann K."/>
        <person name="Hennig S."/>
        <person name="Hernandez J."/>
        <person name="Hinzmann B."/>
        <person name="Ho S."/>
        <person name="Hoffs M."/>
        <person name="Howden P.J."/>
        <person name="Huckle E.J."/>
        <person name="Hume J."/>
        <person name="Hunt P.J."/>
        <person name="Hunt A.R."/>
        <person name="Isherwood J."/>
        <person name="Jacob L."/>
        <person name="Johnson D."/>
        <person name="Jones S."/>
        <person name="de Jong P.J."/>
        <person name="Joseph S.S."/>
        <person name="Keenan S."/>
        <person name="Kelly S."/>
        <person name="Kershaw J.K."/>
        <person name="Khan Z."/>
        <person name="Kioschis P."/>
        <person name="Klages S."/>
        <person name="Knights A.J."/>
        <person name="Kosiura A."/>
        <person name="Kovar-Smith C."/>
        <person name="Laird G.K."/>
        <person name="Langford C."/>
        <person name="Lawlor S."/>
        <person name="Leversha M."/>
        <person name="Lewis L."/>
        <person name="Liu W."/>
        <person name="Lloyd C."/>
        <person name="Lloyd D.M."/>
        <person name="Loulseged H."/>
        <person name="Loveland J.E."/>
        <person name="Lovell J.D."/>
        <person name="Lozado R."/>
        <person name="Lu J."/>
        <person name="Lyne R."/>
        <person name="Ma J."/>
        <person name="Maheshwari M."/>
        <person name="Matthews L.H."/>
        <person name="McDowall J."/>
        <person name="McLaren S."/>
        <person name="McMurray A."/>
        <person name="Meidl P."/>
        <person name="Meitinger T."/>
        <person name="Milne S."/>
        <person name="Miner G."/>
        <person name="Mistry S.L."/>
        <person name="Morgan M."/>
        <person name="Morris S."/>
        <person name="Mueller I."/>
        <person name="Mullikin J.C."/>
        <person name="Nguyen N."/>
        <person name="Nordsiek G."/>
        <person name="Nyakatura G."/>
        <person name="O'dell C.N."/>
        <person name="Okwuonu G."/>
        <person name="Palmer S."/>
        <person name="Pandian R."/>
        <person name="Parker D."/>
        <person name="Parrish J."/>
        <person name="Pasternak S."/>
        <person name="Patel D."/>
        <person name="Pearce A.V."/>
        <person name="Pearson D.M."/>
        <person name="Pelan S.E."/>
        <person name="Perez L."/>
        <person name="Porter K.M."/>
        <person name="Ramsey Y."/>
        <person name="Reichwald K."/>
        <person name="Rhodes S."/>
        <person name="Ridler K.A."/>
        <person name="Schlessinger D."/>
        <person name="Schueler M.G."/>
        <person name="Sehra H.K."/>
        <person name="Shaw-Smith C."/>
        <person name="Shen H."/>
        <person name="Sheridan E.M."/>
        <person name="Shownkeen R."/>
        <person name="Skuce C.D."/>
        <person name="Smith M.L."/>
        <person name="Sotheran E.C."/>
        <person name="Steingruber H.E."/>
        <person name="Steward C.A."/>
        <person name="Storey R."/>
        <person name="Swann R.M."/>
        <person name="Swarbreck D."/>
        <person name="Tabor P.E."/>
        <person name="Taudien S."/>
        <person name="Taylor T."/>
        <person name="Teague B."/>
        <person name="Thomas K."/>
        <person name="Thorpe A."/>
        <person name="Timms K."/>
        <person name="Tracey A."/>
        <person name="Trevanion S."/>
        <person name="Tromans A.C."/>
        <person name="d'Urso M."/>
        <person name="Verduzco D."/>
        <person name="Villasana D."/>
        <person name="Waldron L."/>
        <person name="Wall M."/>
        <person name="Wang Q."/>
        <person name="Warren J."/>
        <person name="Warry G.L."/>
        <person name="Wei X."/>
        <person name="West A."/>
        <person name="Whitehead S.L."/>
        <person name="Whiteley M.N."/>
        <person name="Wilkinson J.E."/>
        <person name="Willey D.L."/>
        <person name="Williams G."/>
        <person name="Williams L."/>
        <person name="Williamson A."/>
        <person name="Williamson H."/>
        <person name="Wilming L."/>
        <person name="Woodmansey R.L."/>
        <person name="Wray P.W."/>
        <person name="Yen J."/>
        <person name="Zhang J."/>
        <person name="Zhou J."/>
        <person name="Zoghbi H."/>
        <person name="Zorilla S."/>
        <person name="Buck D."/>
        <person name="Reinhardt R."/>
        <person name="Poustka A."/>
        <person name="Rosenthal A."/>
        <person name="Lehrach H."/>
        <person name="Meindl A."/>
        <person name="Minx P.J."/>
        <person name="Hillier L.W."/>
        <person name="Willard H.F."/>
        <person name="Wilson R.K."/>
        <person name="Waterston R.H."/>
        <person name="Rice C.M."/>
        <person name="Vaudin M."/>
        <person name="Coulson A."/>
        <person name="Nelson D.L."/>
        <person name="Weinstock G."/>
        <person name="Sulston J.E."/>
        <person name="Durbin R.M."/>
        <person name="Hubbard T."/>
        <person name="Gibbs R.A."/>
        <person name="Beck S."/>
        <person name="Rogers J."/>
        <person name="Bentley D.R."/>
      </authorList>
      <dbReference type="PubMed" id="15772651"/>
      <dbReference type="DOI" id="10.1038/nature03440"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="5">
    <citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <person name="Mural R.J."/>
        <person name="Istrail S."/>
        <person name="Sutton G.G."/>
        <person name="Florea L."/>
        <person name="Halpern A.L."/>
        <person name="Mobarry C.M."/>
        <person name="Lippert R."/>
        <person name="Walenz B."/>
        <person name="Shatkay H."/>
        <person name="Dew I."/>
        <person name="Miller J.R."/>
        <person name="Flanigan M.J."/>
        <person name="Edwards N.J."/>
        <person name="Bolanos R."/>
        <person name="Fasulo D."/>
        <person name="Halldorsson B.V."/>
        <person name="Hannenhalli S."/>
        <person name="Turner R."/>
        <person name="Yooseph S."/>
        <person name="Lu F."/>
        <person name="Nusskern D.R."/>
        <person name="Shue B.C."/>
        <person name="Zheng X.H."/>
        <person name="Zhong F."/>
        <person name="Delcher A.L."/>
        <person name="Huson D.H."/>
        <person name="Kravitz S.A."/>
        <person name="Mouchard L."/>
        <person name="Reinert K."/>
        <person name="Remington K.A."/>
        <person name="Clark A.G."/>
        <person name="Waterman M.S."/>
        <person name="Eichler E.E."/>
        <person name="Adams M.D."/>
        <person name="Hunkapiller M.W."/>
        <person name="Myers E.W."/>
        <person name="Venter J.C."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="6">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
    <source>
      <tissue>Choriocarcinoma</tissue>
    </source>
  </reference>
  <reference key="7">
    <citation type="journal article" date="1998" name="EMBO J." volume="17" first="3681" last="3691">
      <title>Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.</title>
      <authorList>
        <person name="Zhou Q."/>
        <person name="Chen D."/>
        <person name="Pierstorff E."/>
        <person name="Luo K."/>
      </authorList>
      <dbReference type="PubMed" id="9649438"/>
      <dbReference type="DOI" id="10.1093/emboj/17.13.3681"/>
    </citation>
    <scope>INTERACTION WITH CDK9</scope>
  </reference>
  <reference key="8">
    <citation type="journal article" date="1998" name="Genes Dev." volume="12" first="2992" last="2996">
      <title>The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor.</title>
      <authorList>
        <person name="Li X.-Y."/>
        <person name="Green M.R."/>
      </authorList>
      <dbReference type="PubMed" id="9765201"/>
      <dbReference type="DOI" id="10.1101/gad.12.19.2992"/>
    </citation>
    <scope>FUNCTION (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="9">
    <citation type="journal article" date="1998" name="Mol. Cell. Biol." volume="18" first="5000" last="5009">
      <title>CUS2, a yeast homolog of human Tat-SF1, rescues function of misfolded U2 through an unusual RNA recognition motif.</title>
      <authorList>
        <person name="Yan D."/>
        <person name="Perriman R."/>
        <person name="Igel H."/>
        <person name="Howe K.J."/>
        <person name="Neville M."/>
        <person name="Ares M. Jr."/>
      </authorList>
      <dbReference type="PubMed" id="9710584"/>
      <dbReference type="DOI" id="10.1128/mcb.18.9.5000"/>
    </citation>
    <scope>INTERACTION WITH SF3A2</scope>
  </reference>
  <reference key="10">
    <citation type="journal article" date="1999" name="EMBO J." volume="18" first="3688" last="3701">
      <title>A novel RNA polymerase II-containing complex potentiates Tat-enhanced HIV-1 transcription.</title>
      <authorList>
        <person name="Parada C.A."/>
        <person name="Roeder R.G."/>
      </authorList>
      <dbReference type="PubMed" id="10393184"/>
      <dbReference type="DOI" id="10.1093/emboj/18.13.3688"/>
    </citation>
    <scope>FUNCTION (MICROBIAL INFECTION)</scope>
    <scope>IDENTIFICATION IN A COMPLEX WITH NCL; CCNT1; RNA POLYMERASE II; SUPT5H AND CDK9</scope>
  </reference>
  <reference key="11">
    <citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="5960" last="5968">
      <title>Tat-SF1 protein associates with RAP30 and human SPT5 proteins.</title>
      <authorList>
        <person name="Kim J.B."/>
        <person name="Yamaguchi Y."/>
        <person name="Wada T."/>
        <person name="Handa H."/>
        <person name="Sharp P.A."/>
      </authorList>
      <dbReference type="PubMed" id="10454543"/>
      <dbReference type="DOI" id="10.1128/mcb.19.9.5960"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH GTF2F2; SUPT5H AND POLR2A</scope>
  </reference>
  <reference key="12">
    <citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="5897" last="5907">
      <title>Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter.</title>
      <authorList>
        <person name="Fong Y.W."/>
        <person name="Zhou Q."/>
      </authorList>
      <dbReference type="PubMed" id="10913173"/>
      <dbReference type="DOI" id="10.1128/mcb.20.16.5897-5907.2000"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH CCNT1</scope>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2001" name="Immunity" volume="14" first="763" last="777">
      <title>Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators.</title>
      <authorList>
        <person name="Simmons A."/>
        <person name="Aluvihare V."/>
        <person name="McMichael A."/>
      </authorList>
      <dbReference type="PubMed" id="11420046"/>
      <dbReference type="DOI" id="10.1016/s1074-7613(01)00158-3"/>
    </citation>
    <scope>FUNCTION (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2001" name="Nature" volume="414" first="929" last="933">
      <title>Stimulatory effect of splicing factors on transcriptional elongation.</title>
      <authorList>
        <person name="Fong Y.W."/>
        <person name="Zhou Q."/>
      </authorList>
      <dbReference type="PubMed" id="11780068"/>
      <dbReference type="DOI" id="10.1038/414929a"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>MUTAGENESIS OF TYR-136</scope>
    <scope>INTERACTION WITH U SNRNPS AND CCNT1</scope>
    <scope>DOMAIN</scope>
  </reference>
  <reference key="15">
    <citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="9274" last="9285">
      <title>FF domains of CA150 bind transcription and splicing factors through multiple weak interactions.</title>
      <authorList>
        <person name="Smith M.J."/>
        <person name="Kulkarni S."/>
        <person name="Pawson T."/>
      </authorList>
      <dbReference type="PubMed" id="15485897"/>
      <dbReference type="DOI" id="10.1128/mcb.24.21.9274-9285.2004"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
    <scope>INTERACTION WITH TCERG1</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="2005" name="AIDS" volume="19" first="897" last="905">
      <title>Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpression.</title>
      <authorList>
        <person name="Misse D."/>
        <person name="Gajardo J."/>
        <person name="Oblet C."/>
        <person name="Religa A."/>
        <person name="Riquet N."/>
        <person name="Mathieu D."/>
        <person name="Yssel H."/>
        <person name="Veas F."/>
      </authorList>
      <dbReference type="PubMed" id="15905670"/>
      <dbReference type="DOI" id="10.1097/01.aids.0000171403.07995.92"/>
    </citation>
    <scope>FUNCTION (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="17">
    <citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
      <title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Blagoev B."/>
        <person name="Gnad F."/>
        <person name="Macek B."/>
        <person name="Kumar C."/>
        <person name="Mortensen P."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="17081983"/>
      <dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-498; SER-557; SER-561; SER-579; SER-597; SER-600; SER-616; SER-624; SER-642; SER-676; SER-702; SER-713 AND SER-714</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="18">
    <citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
      <title>A quantitative atlas of mitotic phosphorylation.</title>
      <authorList>
        <person name="Dephoure N."/>
        <person name="Zhou C."/>
        <person name="Villen J."/>
        <person name="Beausoleil S.A."/>
        <person name="Bakalarski C.E."/>
        <person name="Elledge S.J."/>
        <person name="Gygi S.P."/>
      </authorList>
      <dbReference type="PubMed" id="18669648"/>
      <dbReference type="DOI" id="10.1073/pnas.0805139105"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-452; SER-453; SER-498; SER-642; SER-713 AND SER-714</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="19">
    <citation type="journal article" date="2008" name="Proteomics" volume="8" first="1346" last="1361">
      <title>Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography.</title>
      <authorList>
        <person name="Han G."/>
        <person name="Ye M."/>
        <person name="Zhou H."/>
        <person name="Jiang X."/>
        <person name="Feng S."/>
        <person name="Jiang X."/>
        <person name="Tian R."/>
        <person name="Wan D."/>
        <person name="Zou H."/>
        <person name="Gu J."/>
      </authorList>
      <dbReference type="PubMed" id="18318008"/>
      <dbReference type="DOI" id="10.1002/pmic.200700884"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-579; SER-616; SER-624; SER-642 AND SER-676</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="20">
    <citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
      <title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
      <authorList>
        <person name="Gauci S."/>
        <person name="Helbig A.O."/>
        <person name="Slijper M."/>
        <person name="Krijgsveld J."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="19413330"/>
      <dbReference type="DOI" id="10.1021/ac9004309"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="21">
    <citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
      <title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
      <authorList>
        <person name="Mayya V."/>
        <person name="Lundgren D.H."/>
        <person name="Hwang S.-I."/>
        <person name="Rezaul K."/>
        <person name="Wu L."/>
        <person name="Eng J.K."/>
        <person name="Rodionov V."/>
        <person name="Han D.K."/>
      </authorList>
      <dbReference type="PubMed" id="19690332"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000007"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-642; SER-702; SER-713 AND SER-714</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Leukemic T-cell</tissue>
    </source>
  </reference>
  <reference key="22">
    <citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
      <title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Vermeulen M."/>
        <person name="Santamaria A."/>
        <person name="Kumar C."/>
        <person name="Miller M.L."/>
        <person name="Jensen L.J."/>
        <person name="Gnad F."/>
        <person name="Cox J."/>
        <person name="Jensen T.S."/>
        <person name="Nigg E.A."/>
        <person name="Brunak S."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="20068231"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000475"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-387; SER-403; SER-407; SER-445; SER-498; SER-579; SER-616; SER-624; THR-633; SER-642; SER-676; SER-702; SER-713; SER-714 AND SER-721</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="23">
    <citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
      <title>Initial characterization of the human central proteome.</title>
      <authorList>
        <person name="Burkard T.R."/>
        <person name="Planyavsky M."/>
        <person name="Kaupe I."/>
        <person name="Breitwieser F.P."/>
        <person name="Buerckstuemmer T."/>
        <person name="Bennett K.L."/>
        <person name="Superti-Furga G."/>
        <person name="Colinge J."/>
      </authorList>
      <dbReference type="PubMed" id="21269460"/>
      <dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="24">
    <citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
      <title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
      <authorList>
        <person name="Rigbolt K.T."/>
        <person name="Prokhorova T.A."/>
        <person name="Akimov V."/>
        <person name="Henningsen J."/>
        <person name="Johansen P.T."/>
        <person name="Kratchmarova I."/>
        <person name="Kassem M."/>
        <person name="Mann M."/>
        <person name="Olsen J.V."/>
        <person name="Blagoev B."/>
      </authorList>
      <dbReference type="PubMed" id="21406692"/>
      <dbReference type="DOI" id="10.1126/scisignal.2001570"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-387; SER-485; SER-579; SER-597; SER-600; SER-607; SER-616; SER-642; SER-676; SER-702; SER-713; SER-714 AND SER-721</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="25">
    <citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
      <title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
      <authorList>
        <person name="Bienvenut W.V."/>
        <person name="Sumpton D."/>
        <person name="Martinez A."/>
        <person name="Lilla S."/>
        <person name="Espagne C."/>
        <person name="Meinnel T."/>
        <person name="Giglione C."/>
      </authorList>
      <dbReference type="PubMed" id="22223895"/>
      <dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="26">
    <citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
      <title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
      <authorList>
        <person name="Van Damme P."/>
        <person name="Lasa M."/>
        <person name="Polevoda B."/>
        <person name="Gazquez C."/>
        <person name="Elosegui-Artola A."/>
        <person name="Kim D.S."/>
        <person name="De Juan-Pardo E."/>
        <person name="Demeyer K."/>
        <person name="Hole K."/>
        <person name="Larrea E."/>
        <person name="Timmerman E."/>
        <person name="Prieto J."/>
        <person name="Arnesen T."/>
        <person name="Sherman F."/>
        <person name="Gevaert K."/>
        <person name="Aldabe R."/>
      </authorList>
      <dbReference type="PubMed" id="22814378"/>
      <dbReference type="DOI" id="10.1073/pnas.1210303109"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="27">
    <citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
      <title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
      <authorList>
        <person name="Zhou H."/>
        <person name="Di Palma S."/>
        <person name="Preisinger C."/>
        <person name="Peng M."/>
        <person name="Polat A.N."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="23186163"/>
      <dbReference type="DOI" id="10.1021/pr300630k"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-445; SER-481; SER-494; SER-498; SER-521; SER-529; SER-579; SER-616; SER-624; SER-642; SER-676; SER-702; SER-713; SER-714 AND SER-721</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
      <tissue>Erythroleukemia</tissue>
    </source>
  </reference>
  <reference key="28">
    <citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
      <title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
      <authorList>
        <person name="Bian Y."/>
        <person name="Song C."/>
        <person name="Cheng K."/>
        <person name="Dong M."/>
        <person name="Wang F."/>
        <person name="Huang J."/>
        <person name="Sun D."/>
        <person name="Wang L."/>
        <person name="Ye M."/>
        <person name="Zou H."/>
      </authorList>
      <dbReference type="PubMed" id="24275569"/>
      <dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-579; SER-642 AND SER-702</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="29">
    <citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
      <title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
      <authorList>
        <person name="Hendriks I.A."/>
        <person name="Lyon D."/>
        <person name="Young C."/>
        <person name="Jensen L.J."/>
        <person name="Vertegaal A.C."/>
        <person name="Nielsen M.L."/>
      </authorList>
      <dbReference type="PubMed" id="28112733"/>
      <dbReference type="DOI" id="10.1038/nsmb.3366"/>
    </citation>
    <scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-429 AND LYS-430</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="30">
    <citation type="journal article" date="2022" name="Mol. Cell" volume="82" first="2571" last="2587">
      <title>A PARylation-phosphorylation cascade promotes TOPBP1 loading and RPA-RAD51 exchange in homologous recombination.</title>
      <authorList>
        <person name="Zhao J."/>
        <person name="Tian S."/>
        <person name="Guo Q."/>
        <person name="Bao K."/>
        <person name="Yu G."/>
        <person name="Wang X."/>
        <person name="Shen X."/>
        <person name="Zhang J."/>
        <person name="Chen J."/>
        <person name="Yang Y."/>
        <person name="Liu L."/>
        <person name="Li X."/>
        <person name="Hao J."/>
        <person name="Yang N."/>
        <person name="Liu Z."/>
        <person name="Ai D."/>
        <person name="Yang J."/>
        <person name="Zhu Y."/>
        <person name="Yao Z."/>
        <person name="Ma S."/>
        <person name="Zhang K."/>
        <person name="Shi L."/>
      </authorList>
      <dbReference type="PubMed" id="35597237"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2022.04.031"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>PHOSPHORYLATION AT SER-748</scope>
    <scope>DOMAIN</scope>
    <scope>INTERACTION WITH RPA1 AND TOPBP1</scope>
    <scope>MUTAGENESIS OF 155-LYS-PHE-156; 297-LYS-PHE-298 AND SER-748</scope>
  </reference>
  <reference key="31">
    <citation type="submission" date="2006-09" db="PDB data bank">
      <title>Solution structure of the RRM_1 domain of HIV Tat specific factor 1 variant.</title>
      <authorList>
        <consortium name="RIKEN structural genomics initiative (RSGI)"/>
      </authorList>
    </citation>
    <scope>STRUCTURE BY NMR OF 256-354</scope>
  </reference>
  <reference evidence="24 25 26" key="32">
    <citation type="journal article" date="2019" name="J. Biol. Chem." volume="294" first="2892" last="2902">
      <title>The pre-mRNA splicing and transcription factor Tat-SF1 is a functional partner of the spliceosome SF3b1 subunit via a U2AF homology motif interface.</title>
      <authorList>
        <person name="Loerch S."/>
        <person name="Leach J.R."/>
        <person name="Horner S.W."/>
        <person name="Maji D."/>
        <person name="Jenkins J.L."/>
        <person name="Pulvino M.J."/>
        <person name="Kielkopf C.L."/>
      </authorList>
      <dbReference type="PubMed" id="30567737"/>
      <dbReference type="DOI" id="10.1074/jbc.ra118.006764"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (1.13 ANGSTROMS) OF 260-353 IN COMPLEX WITH SF3B1</scope>
    <scope>INTERACTION WITH SF3B1</scope>
  </reference>
  <reference evidence="27 28 29" key="33">
    <citation type="journal article" date="2020" name="Nature" volume="583" first="310" last="313">
      <title>Molecular architecture of the human 17S U2 snRNP.</title>
      <authorList>
        <person name="Zhang Z."/>
        <person name="Will C.L."/>
        <person name="Bertram K."/>
        <person name="Dybkov O."/>
        <person name="Hartmuth K."/>
        <person name="Agafonov D.E."/>
        <person name="Hofele R."/>
        <person name="Urlaub H."/>
        <person name="Kastner B."/>
        <person name="Luehrmann R."/>
        <person name="Stark H."/>
      </authorList>
      <dbReference type="PubMed" id="32494006"/>
      <dbReference type="DOI" id="10.1038/s41586-020-2344-3"/>
    </citation>
    <scope>STRUCTURE BY ELECTRON MICROSCOPY (4.10 ANGSTROMS) IN COMPLEX WITH THE 17S U2 SNRNP COMPLEX</scope>
  </reference>
  <reference evidence="30" key="34">
    <citation type="journal article" date="2022" name="Science" volume="375" first="50" last="57">
      <title>Structural basis of branch site recognition by the human spliceosome.</title>
      <authorList>
        <person name="Tholen J."/>
        <person name="Razew M."/>
        <person name="Weis F."/>
        <person name="Galej W.P."/>
      </authorList>
      <dbReference type="PubMed" id="34822310"/>
      <dbReference type="DOI" id="10.1126/science.abm4245"/>
    </citation>
    <scope>STRUCTURE BY ELECTRON MICROSCOPY (2.30 ANGSTROMS) OF 2-755 IN COMPLEX WITH THE 17S U2 SNRNP COMPLEX</scope>
  </reference>
  <reference evidence="31" key="35">
    <citation type="journal article" date="2023" name="Nat. Commun." volume="14" first="897" last="897">
      <title>Mechanisms of the RNA helicases DDX42 and DDX46 in human U2 snRNP assembly.</title>
      <authorList>
        <person name="Yang F."/>
        <person name="Bian T."/>
        <person name="Zhan X."/>
        <person name="Chen Z."/>
        <person name="Xing Z."/>
        <person name="Larsen N.A."/>
        <person name="Zhang X."/>
        <person name="Shi Y."/>
      </authorList>
      <dbReference type="PubMed" id="36797247"/>
      <dbReference type="DOI" id="10.1038/s41467-023-36489-x"/>
    </citation>
    <scope>STRUCTURE BY ELECTRON MICROSCOPY (2.70 ANGSTROMS) IN COMPLEX WITH THE 17S U2 SNRNP COMPLEX</scope>
  </reference>
  <comment type="function">
    <text evidence="5 6 8 11 12 13 14">Component of the 17S U2 SnRNP complex of the spliceosome, a large ribonucleoprotein complex that removes introns from transcribed pre-mRNAs (PubMed:30567737, PubMed:32494006, PubMed:34822310). The 17S U2 SnRNP complex (1) directly participates in early spliceosome assembly and (2) mediates recognition of the intron branch site during pre-mRNA splicing by promoting the selection of the pre-mRNA branch-site adenosine, the nucleophile for the first step of splicing (PubMed:30567737, PubMed:32494006, PubMed:34822310). Within the 17S U2 SnRNP complex, HTATSF1 is required to stabilize the branchpoint-interacting stem loop (PubMed:34822310). HTATSF1 is displaced from the 17S U2 SnRNP complex before the stable addition of the 17S U2 SnRNP complex to the spliceosome, destabilizing the branchpoint-interacting stem loop and allowing to probe intron branch site sequences (PubMed:32494006, PubMed:34822310). Also acts as a regulator of transcriptional elongation, possibly by mediating the reciprocal stimulatory effect of splicing on transcriptional elongation (PubMed:10454543, PubMed:10913173, PubMed:11780068). Involved in double-strand break (DSB) repair via homologous recombination in S-phase by promoting the recruitment of TOPBP1 to DNA damage sites (PubMed:35597237). Mechanistically, HTATSF1 is (1) recruited to DNA damage sites in S-phase via interaction with poly-ADP-ribosylated RPA1 and (2) phosphorylated by CK2, promoting recruitment of TOPBP1, thereby facilitating RAD51 nucleofilaments formation and RPA displacement, followed by homologous recombination (PubMed:35597237).</text>
  </comment>
  <comment type="function">
    <text evidence="4 7 10 15 18">(Microbial infection) In case of infection by HIV-1, it is up-regulated by the HIV-1 proteins NEF and gp120, acts as a cofactor required for the Tat-enhanced transcription of the virus.</text>
  </comment>
  <comment type="subunit">
    <text evidence="4 5 6 8 9 11 12 13 14 16 17">Component of the 17S U2 SnRNP complex, a ribonucleoprotein complex that contains small nuclear RNA (snRNA) U2 and a number of specific proteins (PubMed:11780068, PubMed:30567737, PubMed:32494006, PubMed:34822310, PubMed:9710584). Within the 17S U2 SnRNP complex, interacts (via UHM region) directly with SF3B1 (PubMed:30567737). Component of a complex which is at least composed of HTATSF1/Tat-SF1, the P-TEFb complex components CDK9 and CCNT1, RNA polymerase II, SUPT5H, and NCL/nucleolin (PubMed:10393184, PubMed:10454543, PubMed:10913173, PubMed:11780068, PubMed:9649438). Interacts with GTF2F2/RAP30 and POLR2A (PubMed:10454543). Interacts with TCERG1/CA150 (PubMed:15485897). Interacts with (poly-ADP-ribosylated) RPA1; promoting HTATSF1 recruitment to DNA damage sites (PubMed:35597237). Interacts (when phosphorylated) with TOPBP1; promoting recruitment of TOPBP1 to DNA damage sites during S-phase (PubMed:35597237).</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-720468">
      <id>O43719</id>
    </interactant>
    <interactant intactId="EBI-2462271">
      <id>Q15428</id>
      <label>SF3A2</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-720468">
      <id>O43719</id>
    </interactant>
    <interactant intactId="EBI-15565798">
      <id>O75533-1</id>
      <label>SF3B1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>6</experiments>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location evidence="9 15">Nucleus</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="14">Chromosome</location>
    </subcellularLocation>
    <text evidence="14">Recruited to DNA damage sites during S-phase following interaction with poly-ADP-ribosylated RPA1.</text>
  </comment>
  <comment type="tissue specificity">
    <text evidence="15">Widely expressed.</text>
  </comment>
  <comment type="domain">
    <text evidence="8 14">The RRM domains mediate interaction with U snRNPs (PubMed:11780068). The RRM domains specifically bind poly-ADP-ribosylated RPA1 (PubMed:35597237).</text>
  </comment>
  <comment type="PTM">
    <text evidence="14">Phosphorylation at Ser-748 by CK2 during S-phase in response to DNA damage promotes interaction with TOPBP1 and double-strand break (DSB) repair via homologous recombination.</text>
  </comment>
  <comment type="similarity">
    <text evidence="22">Belongs to the HTATSF1 family.</text>
  </comment>
  <comment type="sequence caution" evidence="22">
    <conflict type="frameshift">
      <sequence resource="EMBL-CDS" id="AAB18823" version="1"/>
    </conflict>
  </comment>
  <comment type="sequence caution" evidence="22">
    <conflict type="erroneous initiation">
      <sequence resource="EMBL-CDS" id="BAD92540" version="1"/>
    </conflict>
  </comment>
  <dbReference type="EMBL" id="U76992">
    <property type="protein sequence ID" value="AAB18823.1"/>
    <property type="status" value="ALT_FRAME"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BT006886">
    <property type="protein sequence ID" value="AAP35532.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AB209303">
    <property type="protein sequence ID" value="BAD92540.1"/>
    <property type="status" value="ALT_INIT"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="Z97632">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="CH471150">
    <property type="protein sequence ID" value="EAW88468.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="CH471150">
    <property type="protein sequence ID" value="EAW88469.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC009896">
    <property type="protein sequence ID" value="AAH09896.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS14657.1"/>
  <dbReference type="RefSeq" id="NP_001156752.1">
    <property type="nucleotide sequence ID" value="NM_001163280.1"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_055315.2">
    <property type="nucleotide sequence ID" value="NM_014500.4"/>
  </dbReference>
  <dbReference type="RefSeq" id="XP_005262461.1">
    <property type="nucleotide sequence ID" value="XM_005262404.3"/>
  </dbReference>
  <dbReference type="PDB" id="2DIT">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=256-354"/>
  </dbReference>
  <dbReference type="PDB" id="6N3D">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.13 A"/>
    <property type="chains" value="A=260-353"/>
  </dbReference>
  <dbReference type="PDB" id="6N3E">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.89 A"/>
    <property type="chains" value="A=260-353"/>
  </dbReference>
  <dbReference type="PDB" id="6N3F">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.10 A"/>
    <property type="chains" value="A/C=260-353"/>
  </dbReference>
  <dbReference type="PDB" id="6NSX">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.00 A"/>
    <property type="chains" value="A=260-353"/>
  </dbReference>
  <dbReference type="PDB" id="6Y50">
    <property type="method" value="EM"/>
    <property type="resolution" value="4.10 A"/>
    <property type="chains" value="q=1-755"/>
  </dbReference>
  <dbReference type="PDB" id="6Y53">
    <property type="method" value="EM"/>
    <property type="resolution" value="7.10 A"/>
    <property type="chains" value="q=1-755"/>
  </dbReference>
  <dbReference type="PDB" id="6Y5Q">
    <property type="method" value="EM"/>
    <property type="resolution" value="7.10 A"/>
    <property type="chains" value="q=1-755"/>
  </dbReference>
  <dbReference type="PDB" id="7EVO">
    <property type="method" value="EM"/>
    <property type="resolution" value="2.50 A"/>
    <property type="chains" value="D=1-755"/>
  </dbReference>
  <dbReference type="PDB" id="7Q3L">
    <property type="method" value="EM"/>
    <property type="resolution" value="2.30 A"/>
    <property type="chains" value="q=2-755"/>
  </dbReference>
  <dbReference type="PDB" id="8HK1">
    <property type="method" value="EM"/>
    <property type="resolution" value="2.70 A"/>
    <property type="chains" value="D=1-755"/>
  </dbReference>
  <dbReference type="PDBsum" id="2DIT"/>
  <dbReference type="PDBsum" id="6N3D"/>
  <dbReference type="PDBsum" id="6N3E"/>
  <dbReference type="PDBsum" id="6N3F"/>
  <dbReference type="PDBsum" id="6NSX"/>
  <dbReference type="PDBsum" id="6Y50"/>
  <dbReference type="PDBsum" id="6Y53"/>
  <dbReference type="PDBsum" id="6Y5Q"/>
  <dbReference type="PDBsum" id="7EVO"/>
  <dbReference type="PDBsum" id="7Q3L"/>
  <dbReference type="PDBsum" id="8HK1"/>
  <dbReference type="AlphaFoldDB" id="O43719"/>
  <dbReference type="EMDB" id="EMD-10688"/>
  <dbReference type="EMDB" id="EMD-10689"/>
  <dbReference type="EMDB" id="EMD-13793"/>
  <dbReference type="EMDB" id="EMD-31334"/>
  <dbReference type="EMDB" id="EMD-34841"/>
  <dbReference type="SMR" id="O43719"/>
  <dbReference type="BioGRID" id="118149">
    <property type="interactions" value="146"/>
  </dbReference>
  <dbReference type="ComplexPortal" id="CPX-2539">
    <property type="entry name" value="U2 small nuclear ribonucleoprotein complex"/>
  </dbReference>
  <dbReference type="CORUM" id="O43719"/>
  <dbReference type="DIP" id="DIP-42095N"/>
  <dbReference type="IntAct" id="O43719">
    <property type="interactions" value="62"/>
  </dbReference>
  <dbReference type="MINT" id="O43719"/>
  <dbReference type="STRING" id="9606.ENSP00000442699"/>
  <dbReference type="GlyGen" id="O43719">
    <property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="O43719"/>
  <dbReference type="MetOSite" id="O43719"/>
  <dbReference type="PhosphoSitePlus" id="O43719"/>
  <dbReference type="BioMuta" id="HTATSF1"/>
  <dbReference type="jPOST" id="O43719"/>
  <dbReference type="MassIVE" id="O43719"/>
  <dbReference type="PaxDb" id="9606-ENSP00000442699"/>
  <dbReference type="PeptideAtlas" id="O43719"/>
  <dbReference type="ProteomicsDB" id="49133"/>
  <dbReference type="Pumba" id="O43719"/>
  <dbReference type="Antibodypedia" id="375">
    <property type="antibodies" value="310 antibodies from 35 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="27336"/>
  <dbReference type="Ensembl" id="ENST00000218364.5">
    <property type="protein sequence ID" value="ENSP00000218364.4"/>
    <property type="gene ID" value="ENSG00000102241.12"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000535601.5">
    <property type="protein sequence ID" value="ENSP00000442699.1"/>
    <property type="gene ID" value="ENSG00000102241.12"/>
  </dbReference>
  <dbReference type="GeneID" id="27336"/>
  <dbReference type="KEGG" id="hsa:27336"/>
  <dbReference type="MANE-Select" id="ENST00000218364.5">
    <property type="protein sequence ID" value="ENSP00000218364.4"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_014500.5"/>
    <property type="RefSeq protein sequence ID" value="NP_055315.2"/>
  </dbReference>
  <dbReference type="UCSC" id="uc004ezw.4">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:5276"/>
  <dbReference type="CTD" id="27336"/>
  <dbReference type="DisGeNET" id="27336"/>
  <dbReference type="GeneCards" id="HTATSF1"/>
  <dbReference type="HGNC" id="HGNC:5276">
    <property type="gene designation" value="HTATSF1"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000102241">
    <property type="expression patterns" value="Low tissue specificity"/>
  </dbReference>
  <dbReference type="MIM" id="300346">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_O43719"/>
  <dbReference type="OpenTargets" id="ENSG00000102241"/>
  <dbReference type="PharmGKB" id="PA29540"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000102241"/>
  <dbReference type="eggNOG" id="KOG1548">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00390000009902"/>
  <dbReference type="HOGENOM" id="CLU_406872_0_0_1"/>
  <dbReference type="InParanoid" id="O43719"/>
  <dbReference type="OMA" id="DGGEFKE"/>
  <dbReference type="OrthoDB" id="10213at2759"/>
  <dbReference type="PhylomeDB" id="O43719"/>
  <dbReference type="TreeFam" id="TF313623"/>
  <dbReference type="PathwayCommons" id="O43719"/>
  <dbReference type="Reactome" id="R-HSA-72163">
    <property type="pathway name" value="mRNA Splicing - Major Pathway"/>
  </dbReference>
  <dbReference type="SignaLink" id="O43719"/>
  <dbReference type="SIGNOR" id="O43719"/>
  <dbReference type="BioGRID-ORCS" id="27336">
    <property type="hits" value="371 hits in 788 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="HTATSF1">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="O43719"/>
  <dbReference type="GeneWiki" id="HTATSF1"/>
  <dbReference type="GenomeRNAi" id="27336"/>
  <dbReference type="Pharos" id="O43719">
    <property type="development level" value="Tbio"/>
  </dbReference>
  <dbReference type="PRO" id="PR:O43719"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome X"/>
  </dbReference>
  <dbReference type="RNAct" id="O43719">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000102241">
    <property type="expression patterns" value="Expressed in sural nerve and 218 other cell types or tissues"/>
  </dbReference>
  <dbReference type="ExpressionAtlas" id="O43719">
    <property type="expression patterns" value="baseline and differential"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005654">
    <property type="term" value="C:nucleoplasm"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005634">
    <property type="term" value="C:nucleus"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0035861">
    <property type="term" value="C:site of double-strand break"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005681">
    <property type="term" value="C:spliceosomal complex"/>
    <property type="evidence" value="ECO:0000303"/>
    <property type="project" value="ComplexPortal"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005686">
    <property type="term" value="C:U2 snRNP"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005684">
    <property type="term" value="C:U2-type spliceosomal complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140463">
    <property type="term" value="F:chromatin-protein adaptor activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0160004">
    <property type="term" value="F:poly-ADP-D-ribose modification-dependent protein binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003723">
    <property type="term" value="F:RNA binding"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0000724">
    <property type="term" value="P:double-strand break repair via homologous recombination"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0000398">
    <property type="term" value="P:mRNA splicing, via spliceosome"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:1990166">
    <property type="term" value="P:protein localization to site of double-strand break"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:1903241">
    <property type="term" value="P:U2-type prespliceosome assembly"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="CDD" id="cd12281">
    <property type="entry name" value="RRM1_TatSF1_like"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="CDD" id="cd12282">
    <property type="entry name" value="RRM2_TatSF1_like"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.30.70.330">
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR012677">
    <property type="entry name" value="Nucleotide-bd_a/b_plait_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR035979">
    <property type="entry name" value="RBD_domain_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR000504">
    <property type="entry name" value="RRM_dom"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR034393">
    <property type="entry name" value="TatSF1-like"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR034392">
    <property type="entry name" value="TatSF1-like_RRM1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR15608:SF0">
    <property type="entry name" value="HIV TAT-SPECIFIC FACTOR 1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR15608">
    <property type="entry name" value="SPLICING FACTOR U2AF-ASSOCIATED PROTEIN 2"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF00076">
    <property type="entry name" value="RRM_1"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="SMART" id="SM00360">
    <property type="entry name" value="RRM"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF54928">
    <property type="entry name" value="RNA-binding domain, RBD"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50102">
    <property type="entry name" value="RRM"/>
    <property type="match status" value="2"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0007">Acetylation</keyword>
  <keyword id="KW-0010">Activator</keyword>
  <keyword id="KW-0158">Chromosome</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0227">DNA damage</keyword>
  <keyword id="KW-0234">DNA repair</keyword>
  <keyword id="KW-1017">Isopeptide bond</keyword>
  <keyword id="KW-0507">mRNA processing</keyword>
  <keyword id="KW-0508">mRNA splicing</keyword>
  <keyword id="KW-0539">Nucleus</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0677">Repeat</keyword>
  <keyword id="KW-0694">RNA-binding</keyword>
  <keyword id="KW-0747">Spliceosome</keyword>
  <keyword id="KW-0804">Transcription</keyword>
  <keyword id="KW-0805">Transcription regulation</keyword>
  <keyword id="KW-0832">Ubl conjugation</keyword>
  <feature type="initiator methionine" description="Removed" evidence="35 39 40">
    <location>
      <position position="1"/>
    </location>
  </feature>
  <feature type="chain" id="PRO_0000248604" description="17S U2 SnRNP complex component HTATSF1">
    <location>
      <begin position="2"/>
      <end position="755"/>
    </location>
  </feature>
  <feature type="domain" description="RRM 1" evidence="2">
    <location>
      <begin position="133"/>
      <end position="218"/>
    </location>
  </feature>
  <feature type="domain" description="RRM 2" evidence="2">
    <location>
      <begin position="264"/>
      <end position="349"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="3">
    <location>
      <begin position="1"/>
      <end position="53"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="3">
    <location>
      <begin position="81"/>
      <end position="122"/>
    </location>
  </feature>
  <feature type="region of interest" description="U2AF homology motif (UHM)" evidence="11">
    <location>
      <begin position="259"/>
      <end position="353"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="3">
    <location>
      <begin position="380"/>
      <end position="415"/>
    </location>
  </feature>
  <feature type="region of interest" description="Mediates interaction with the P-TEFb complex" evidence="16">
    <location>
      <begin position="381"/>
      <end position="755"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="3">
    <location>
      <begin position="433"/>
      <end position="755"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Basic and acidic residues" evidence="3">
    <location>
      <begin position="10"/>
      <end position="33"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Basic and acidic residues" evidence="3">
    <location>
      <begin position="92"/>
      <end position="122"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Basic and acidic residues" evidence="3">
    <location>
      <begin position="433"/>
      <end position="473"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Basic and acidic residues" evidence="3">
    <location>
      <begin position="488"/>
      <end position="534"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Acidic residues" evidence="3">
    <location>
      <begin position="535"/>
      <end position="549"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Basic and acidic residues" evidence="3">
    <location>
      <begin position="550"/>
      <end position="593"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Acidic residues" evidence="3">
    <location>
      <begin position="594"/>
      <end position="651"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Basic and acidic residues" evidence="3">
    <location>
      <begin position="652"/>
      <end position="669"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Acidic residues" evidence="3">
    <location>
      <begin position="670"/>
      <end position="717"/>
    </location>
  </feature>
  <feature type="modified residue" description="N-acetylserine" evidence="35 39 40">
    <location>
      <position position="2"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-acetyllysine" evidence="1">
    <location>
      <position position="297"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="37 38">
    <location>
      <position position="387"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="37">
    <location>
      <position position="403"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="37">
    <location>
      <position position="407"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="1">
    <location>
      <position position="409"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="37 41">
    <location>
      <position position="445"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="34">
    <location>
      <position position="452"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="34">
    <location>
      <position position="453"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="41">
    <location>
      <position position="481"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="38">
    <location>
      <position position="485"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="41">
    <location>
      <position position="494"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="32 34 37 41">
    <location>
      <position position="498"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="41">
    <location>
      <position position="521"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="41">
    <location>
      <position position="529"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="32">
    <location>
      <position position="557"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="32">
    <location>
      <position position="561"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="32 33 37 38 41 42">
    <location>
      <position position="579"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="32 38">
    <location>
      <position position="597"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="32 38">
    <location>
      <position position="600"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="38">
    <location>
      <position position="607"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="32 33 37 38 41">
    <location>
      <position position="616"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="32 33 37 41">
    <location>
      <position position="624"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine" evidence="37">
    <location>
      <position position="633"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="32 33 34 36 37 38 41 42">
    <location>
      <position position="642"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="32 33 37 38 41">
    <location>
      <position position="676"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="32 36 37 38 41 42">
    <location>
      <position position="702"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="32 34 36 37 38 41">
    <location>
      <position position="713"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="32 34 36 37 38 41">
    <location>
      <position position="714"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="37 38 41">
    <location>
      <position position="721"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine; by CK2" evidence="14">
    <location>
      <position position="748"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="43">
    <location>
      <position position="429"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="43">
    <location>
      <position position="430"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_027362" description="In dbSNP:rs2071913." evidence="19">
    <original>G</original>
    <variation>A</variation>
    <location>
      <position position="478"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_052206" description="In dbSNP:rs12852634.">
    <original>N</original>
    <variation>T</variation>
    <location>
      <position position="526"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_052207" description="In dbSNP:rs17339410.">
    <original>D</original>
    <variation>G</variation>
    <location>
      <position position="678"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of interaction with U snRNPs." evidence="8">
    <original>Y</original>
    <variation>D</variation>
    <location>
      <position position="136"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In 4A mutant; abolished binding to poly-ADP-ribosylated RPA1 and recruitment to DNA damage sites; when associated with 297-A-A-298." evidence="14">
    <original>KF</original>
    <variation>AA</variation>
    <location>
      <begin position="155"/>
      <end position="156"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In 4A mutant; abolished binding to poly-ADP-ribosylated RPA1 and recruitment to DNA damage sites; when associated with 155-A-A-156." evidence="14">
    <original>KF</original>
    <variation>AA</variation>
    <location>
      <begin position="297"/>
      <end position="298"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Impaired phosphorylation by CK2, leading to abolish interaction with TOPBP1." evidence="14">
    <original>S</original>
    <variation>A</variation>
    <location>
      <position position="748"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 3; BAD92540." evidence="22" ref="3">
    <original>F</original>
    <variation>V</variation>
    <location>
      <position position="125"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 3; BAD92540." evidence="22" ref="3">
    <original>V</original>
    <variation>I</variation>
    <location>
      <position position="587"/>
    </location>
  </feature>
  <feature type="strand" evidence="46">
    <location>
      <begin position="134"/>
      <end position="139"/>
    </location>
  </feature>
  <feature type="helix" evidence="46">
    <location>
      <begin position="146"/>
      <end position="154"/>
    </location>
  </feature>
  <feature type="strand" evidence="45">
    <location>
      <begin position="165"/>
      <end position="174"/>
    </location>
  </feature>
  <feature type="strand" evidence="45">
    <location>
      <begin position="176"/>
      <end position="178"/>
    </location>
  </feature>
  <feature type="strand" evidence="46">
    <location>
      <begin position="185"/>
      <end position="190"/>
    </location>
  </feature>
  <feature type="helix" evidence="46">
    <location>
      <begin position="192"/>
      <end position="200"/>
    </location>
  </feature>
  <feature type="turn" evidence="46">
    <location>
      <begin position="201"/>
      <end position="203"/>
    </location>
  </feature>
  <feature type="strand" evidence="46">
    <location>
      <begin position="212"/>
      <end position="214"/>
    </location>
  </feature>
  <feature type="helix" evidence="46">
    <location>
      <begin position="241"/>
      <end position="244"/>
    </location>
  </feature>
  <feature type="helix" evidence="44">
    <location>
      <begin position="261"/>
      <end position="264"/>
    </location>
  </feature>
  <feature type="strand" evidence="44">
    <location>
      <begin position="265"/>
      <end position="269"/>
    </location>
  </feature>
  <feature type="helix" evidence="44">
    <location>
      <begin position="274"/>
      <end position="277"/>
    </location>
  </feature>
  <feature type="helix" evidence="44">
    <location>
      <begin position="282"/>
      <end position="295"/>
    </location>
  </feature>
  <feature type="turn" evidence="44">
    <location>
      <begin position="296"/>
      <end position="298"/>
    </location>
  </feature>
  <feature type="strand" evidence="44">
    <location>
      <begin position="301"/>
      <end position="306"/>
    </location>
  </feature>
  <feature type="strand" evidence="44">
    <location>
      <begin position="315"/>
      <end position="321"/>
    </location>
  </feature>
  <feature type="helix" evidence="44">
    <location>
      <begin position="322"/>
      <end position="332"/>
    </location>
  </feature>
  <feature type="strand" evidence="44">
    <location>
      <begin position="343"/>
      <end position="346"/>
    </location>
  </feature>
  <evidence type="ECO:0000250" key="1">
    <source>
      <dbReference type="UniProtKB" id="Q8BGC0"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="2">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00176"/>
    </source>
  </evidence>
  <evidence type="ECO:0000256" key="3">
    <source>
      <dbReference type="SAM" id="MobiDB-lite"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="4">
    <source>
      <dbReference type="PubMed" id="10393184"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="5">
    <source>
      <dbReference type="PubMed" id="10454543"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="10913173"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="11420046"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="11780068"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="15485897"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="15905670"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="30567737"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="32494006"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="34822310"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="35597237"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="8849451"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="9649438"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="17">
    <source>
      <dbReference type="PubMed" id="9710584"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="18">
    <source>
      <dbReference type="PubMed" id="9765201"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="19">
    <source ref="3"/>
  </evidence>
  <evidence type="ECO:0000303" key="20">
    <source>
      <dbReference type="PubMed" id="35597237"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="21">
    <source>
      <dbReference type="PubMed" id="8849451"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="22"/>
  <evidence type="ECO:0000312" key="23">
    <source>
      <dbReference type="HGNC" id="HGNC:5276"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="24">
    <source>
      <dbReference type="PDB" id="6N3D"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="25">
    <source>
      <dbReference type="PDB" id="6N3E"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="26">
    <source>
      <dbReference type="PDB" id="6N3F"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="27">
    <source>
      <dbReference type="PDB" id="6Y50"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="28">
    <source>
      <dbReference type="PDB" id="6Y53"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="29">
    <source>
      <dbReference type="PDB" id="6Y5Q"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="30">
    <source>
      <dbReference type="PDB" id="7Q3L"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="31">
    <source>
      <dbReference type="PDB" id="8HK1"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="32">
    <source>
      <dbReference type="PubMed" id="17081983"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="33">
    <source>
      <dbReference type="PubMed" id="18318008"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="34">
    <source>
      <dbReference type="PubMed" id="18669648"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="35">
    <source>
      <dbReference type="PubMed" id="19413330"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="36">
    <source>
      <dbReference type="PubMed" id="19690332"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="37">
    <source>
      <dbReference type="PubMed" id="20068231"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="38">
    <source>
      <dbReference type="PubMed" id="21406692"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="39">
    <source>
      <dbReference type="PubMed" id="22223895"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="40">
    <source>
      <dbReference type="PubMed" id="22814378"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="41">
    <source>
      <dbReference type="PubMed" id="23186163"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="42">
    <source>
      <dbReference type="PubMed" id="24275569"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="43">
    <source>
      <dbReference type="PubMed" id="28112733"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="44">
    <source>
      <dbReference type="PDB" id="6N3D"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="45">
    <source>
      <dbReference type="PDB" id="7EVO"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="46">
    <source>
      <dbReference type="PDB" id="7Q3L"/>
    </source>
  </evidence>
  <sequence length="755" mass="85853" checksum="C9CA6C89E4F2A319" modified="1998-06-01" version="1">MSGTNLDGNDEFDEQLRMQELYGDGKDGDTQTDAGGEPDSLGQQPTDTPYEWDLDKKAWFPKITEDFIATYQANYGFSNDGASSSTANVEDVHARTAEEPPQEKAPEPTDARKKGEKRKAESGWFHVEEDRNTNVYVSGLPPDITVDEFIQLMSKFGIIMRDPQTEEFKVKLYKDNQGNLKGDGLCCYLKRESVELALKLLDEDEIRGYKLHVEVAKFQLKGEYDASKKKKKCKDYKKKLSMQQKQLDWRPERRAGPSRMRHERVVIIKNMFHPMDFEDDPLVLNEIREDLRVECSKFGQIRKLLLFDRHPDGVASVSFRDPEEADYCIQTLDGRWFGGRQITAQAWDGTTDYQVEETSREREERLRGWEAFLNAPEANRGLRRSDSVSASERAGPSRARHFSEHPSTSKMNAQETATGMAFEEPIDEKKFEKTEDGGEFEEGASENNAKESSPEKEAEEGCPEKESEEGCPKRGFEGSCSQKESEEGNPVRGSEEDSPKKESKKKTLKNDCEENGLAKESEDDLNKESEEEVGPTKESEEDDSEKESDEDCSEKQSEDGSEREFEENGLEKDLDEEGSEKELHENVLDKELEENDSENSEFEDDGSEKVLDEEGSEREFDEDSDEKEEEEDTYEKVFDDESDEKEDEEYADEKGLEAADKKAEEGDADEKLFEESDDKEDEDADGKEVEDADEKLFEDDDSNEKLFDEEEDSSEKLFDDSDERGTLGGFGSVEEGPLSTGSSFILSSDDDDDDI</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>